A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

Clinical trial NCT05614063 · COMPLETED

Trial details

NCT number: NCT05614063
Sponsor: Xenon Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Focal Onset Seizures

Start date: 2022-11-18
Primary completion: 2026-01-12
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.